CMF-03047 | OR5D14 | up-regulates | RUNX1 | activates | R-275 | 15 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-13811 | ADAMTS8 | down-regulates | RUNX1 | activates | R-275 | 15 | 7 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-21660 | MUC17 | up-regulates | RUNX1 | activates | R-275 | 15 | 8 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-23809 | TP53 | down-regulates | RUNX1 | activates | R-275 | 15 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-30633 | SALL4 | down-regulates | RUNX1 | activates | R-275 | 15 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-33893 | SKAP2 | down-regulates | hsa-mir-641 | represses | R-275 | 8 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-33920 | SDPR | down-regulates | hsa-mir-30b | represses | R-275 | 9 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-34858 | NEB | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-34863 | NEB | down-regulates | hsa-mir-301 | represses | R-275 | 37 | 7 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35050 | FGFR3 | down-regulates | hsa-mir-454-3p | represses | R-275 | 31 | 29 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35081 | FGFR3 | down-regulates | hsa-mir-20b | represses | R-275 | 44 | 26 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35168 | APOF | down-regulates | hsa-mir-361 | represses | R-275 | 14 | 2 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35191 | SCNN1G | up-regulates | hsa-mir-106b | represses | R-275 | 21 | 13 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35739 | NELL1 | down-regulates | hsa-mir-20b | represses | R-275 | 44 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35958 | AHNAK2 | up-regulates | hsa-mir-361 | represses | R-275 | 14 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35972 | AHNAK2 | up-regulates | hsa-mir-106b | represses | R-275 | 21 | 16 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-35994 | AHNAK2 | up-regulates | hsa-mir-93 | represses | R-275 | 44 | 26 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36022 | AHNAK2 | up-regulates | hsa-mir-20b | represses | R-275 | 44 | 26 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36148 | TNK2 | up-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 40 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36375 | DIAPH2 | up-regulates | hsa-mir-30b | represses | R-275 | 9 | 2 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36678 | ALB | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36688 | ATP8A2 | up-regulates | hsa-mir-454-3p | represses | R-275 | 31 | 27 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36724 | ATP8A2 | up-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 40 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36757 | ATP8A2 | up-regulates | hsa-mir-93 | represses | R-275 | 44 | 32 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-36791 | ATP8A2 | up-regulates | hsa-mir-20b | represses | R-275 | 44 | 31 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-37169 | CYP4F22 | down-regulates | hsa-mir-7 | represses | R-275 | 18 | 17 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-37183 | CYP4F22 | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 18 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-37691 | ADAMTS8 | up-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 40 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-37871 | PRKCD | up-regulates | hsa-mir-641 | represses | R-275 | 8 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-37958 | COL6A2 | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 17 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38085 | OR51F1 | up-regulates | hsa-mir-106b | represses | R-275 | 21 | 17 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38104 | OR51F1 | up-regulates | hsa-mir-93 | represses | R-275 | 44 | 35 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38320 | ZNF845 | up-regulates | hsa-mir-454-3p | represses | R-275 | 31 | 27 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38346 | ZNF845 | up-regulates | hsa-mir-641 | represses | R-275 | 8 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38406 | KCNB2 | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38411 | KCNB2 | down-regulates | hsa-mir-361 | represses | R-275 | 14 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38415 | KCNB2 | down-regulates | hsa-mir-301 | represses | R-275 | 37 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38424 | KCNB2 | down-regulates | hsa-mir-106b | represses | R-275 | 21 | 15 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38445 | KCNB2 | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 36 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38476 | KCNB2 | down-regulates | hsa-mir-93 | represses | R-275 | 44 | 27 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38566 | CPNE8 | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 28 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-38589 | CPNE8 | down-regulates | hsa-mir-93 | represses | R-275 | 44 | 20 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39137 | DNMBP | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 35 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39333 | INPP5J | up-regulates | hsa-mir-641 | represses | R-275 | 8 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39743 | RPSAP58 | down-regulates | hsa-mir-301 | represses | R-275 | 37 | 12 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39766 | RPSAP58 | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 40 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39794 | RPSAP58 | down-regulates | hsa-mir-641 | represses | R-275 | 8 | 7 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39856 | OR6C75 | down-regulates | hsa-mir-30b | represses | R-275 | 9 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39900 | TDRD9 | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 16 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39915 | TDRD9 | down-regulates | hsa-mir-361 | represses | R-275 | 14 | 9 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39928 | TDRD9 | down-regulates | hsa-mir-106b | represses | R-275 | 21 | 21 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-39958 | TDRD9 | down-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 42 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-40135 | STAB2 | up-regulates | hsa-mir-106b | represses | R-275 | 21 | 8 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-40309 | MUC17 | down-regulates | hsa-mir-30b | represses | R-275 | 9 | 9 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-41268 | TP53 | up-regulates | hsa-mir-301 | represses | R-275 | 37 | 28 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-41331 | TP53 | up-regulates | hsa-mir-17-3p | represses | R-275 | 52 | 52 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-41377 | TP53 | up-regulates | hsa-mir-93 | represses | R-275 | 44 | 44 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-41538 | TP53 | up-regulates | hsa-mir-20b | represses | R-275 | 44 | 44 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-41612 | PREX1 | down-regulates | hsa-mir-7 | represses | R-275 | 18 | 1 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-42184 | NAALADL1 | down-regulates | hsa-mir-301 | represses | R-275 | 37 | 10 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-42352 | SDK1 | down-regulates | hsa-mir-7 | represses | R-275 | 18 | 14 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-42390 | KRTAP20-2 | down-regulates | hsa-mir-7 | represses | R-275 | 18 | 15 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-42419 | ANKRD36 | down-regulates | hsa-mir-30d | represses | R-275 | 29 | 11 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-42439 | ANKRD36 | down-regulates | hsa-mir-641 | represses | R-275 | 8 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-43250 | PROKR2 | up-regulates | hsa-mir-30b | represses | R-275 | 9 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |
CMF-43338 | LRFN2 | up-regulates | hsa-mir-30b | represses | R-275 | 9 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)RUPATADINE, DASATINIB, ABATACEPT, L19IL2, AS-1409, AMY-101, MEDI-2338, CAROTUXIMAB, L19TNFA, BOSUTINIB, BAFETINIB, ILORASERTIB, DAPANSUTRILE, JNJ-26483327, L19SIP 131I, TADEKINIG ALFA, NEIHULIZUMAB, BELATACEPT, XL-228, SELGANTOLIMOD, TOLIMIDONE, MOTOLIMOD, TG100-801, PEGCETACOPLAN, TELRATOLIMOD, OCRIPLASMIN, GSK-1070806, AL-78898A, ENMD-981693 |